Professionisti del settore sanitario

Secura DR and VR

Implantable Cardioverter Defibrillators (ICDs)

Secura DR and VR ICD

Secura® DR and VR implantable cardioverter defibrillators (ICDs) for tachycardia therapy are part of the Vision 3D™ Portfolio and include Complete Capture Management and OptiVol® Fluid Status Monitoring for predicting worsening heart failure.

Vision 3D Fundamentals

Vision 3D Portfolio for Individual Patient Needs

Vision 3D Fundamentals

Vision 3D™ Fundamentals are the foundation of the Vision 3D Portfolio, a comprehensive family of ICDs and biventricular devices to meet your individual patient's therapy goals.

Vision 3D Fundamentals include:

  • Proven cardioverter shock reduction and atrial therapy1
  • Dual chamber managed ventricular pacing2
  • Industry-leading diagnostics and reporting such as Cardiac Compass®
  • Medtronic Conexus® wireless remote cardiac telemetry, part of Medtronic CareLink® Network
Espandi tutto

How It Works

Secura ICD – Proven Solution for Tachycardia Therapy

The first and only completely automatic, wireless implantable cardioverter defibrillator (ICD) to combine industry-leading pacing, wireless remote cardiac telemetry, and ICD exclusives:

 


Important Safety Information

Changes in a patient’s disease and/or medications may alter the efficacy of a device’s programmed parameters or related features.


Completely Automatic – Complete Capture Management

Secura ICDs include Complete Capture Management, which:

  • Ensures capture in all heart chambers – atrial capture management, left ventricular capture management, and right ventricular capture management
  • Provides a daily complete device check – automatically:
    • Lead impedance
    • Battery status
    • All-chamber threshold evaluation
    • Sensing amplitudes
  • Eliminates the need for manual threshold checks, freeing time for your clinic patients
  • Adapts therapies automatically to changing patient needs

Timely, Efficient Follow-up With Wireless Remote Cardiac Telemetry

The same in-depth device information as an office visit:

Programmable SCV

Programming flexibility reduces risks for patients

Programmable Options Provide Noninvasive Solutions for Complex Cases

  • Choose a different vector to resolve sensing issues that may lead to unnecessary cardioverter shocks using programmable RV sensing
  • Avoid surgical intervention and enhance safety for your patients with high DFTs using Programmable SVC and Active Can®

References

1

Medtronic Secura™ ICD System Reference Guide

2

Gillis AM, Pürerfellner H, Israel CW, et al. Reduction of unnecessary ventricular pacing due to the Managed Ventricular Pacing (MVP) mode in pacemaker patients: benefit for both sinus node disease (SND) and AV block (AVB) indications. Heart Rhythm. 2005;Abstract AB21-1.

Specs


References

1

Wathen MS, DeGroot PJ, Sweeny MO, et al, for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. October 26, 2004;110(17):2591-2596.

2

Gillis AM, Pürerfellner H, Israel CW, et al. Reduction of unnecessary ventricular pacing due to the Managed Ventricular Pacing (MVP) mode in pacemaker patients: benefit for both sinus node disease (SND) and AV block (AVB) indications. Heart Rhythm. 2005;Abstract AB21-1.